Restricted Cash (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2025

Dec. 31, 2024

Cara Therapeutics, Inc.

Schedule of Reconciliation of Cash, Cash Equivalents and Restricted Cash

	March 31, 2025		December 31, 2024
Cash and cash equivalents	$	34,217	$	37,903
Restricted cash, current assets		—		—
Restricted cash, long-term assets		—		—
Total cash, cash equivalents, and restricted cash shown in the Condensed Consolidated Statements of Cash Flows	$	34,217	$	37,903

	December 31, 2024		December 31, 2023
Cash and cash equivalents	$	37,903	$	51,775
Restricted cash, current assets		—		408
Restricted cash, long-term assets		—		1,500
Total cash, cash equivalents, and restricted cash shown in the Consolidated Statements of Cash Flows	$	37,903	$	53,683